A new meta-analysis finds no clear long-term cardiovascular benefit from beta-blockers after myocardial infarction in ...
Beta-thalassemia, also called Cooley’s Anemia, is a blood disease that effects thousands of Americans. In a major step toward a curative therapy, rare disease drug development firm Errant Gene ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback